GlassScriptPhysician profile
Michael V Yao
NPI 1861734543
$1,036.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.54 · 2021: $182 · 2022: $386 · 2023: $267 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.96 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $397.51 | 2021-2023 | Omnipod |
| Ascendis Pharma Endocrinology INC | $268.02 | 2022-2024 | |
| Dexcom, INC. | $110.80 | 2020-2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $45.14 | 2021-2023 | Inpen Smart Insulin Delivery System |
| Tandem Diabetes Care, INC. | $42.50 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $41.94 | 2021-2022 | |
| Cordis US Corp. | $36.48 | 2021 | |
| Novo Nordisk INC | $32.27 | 2023 | Sogroya |
| Arbor Pharmaceuticals, INC. | $24.68 | 2021 | |
| Xeris Pharmaceuticals, INC. | $24.01 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $13.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.